Evaluation of presepsin dynamics in septic patients with and without liver cirrhosis
References
- Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801–10.
- Kang C, Choi S, Jang EJ, Joo S, et al. Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016. BMC Infect Dis. 2024 Feb 12;24(1):184.
- Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010 Oct;139(4):1246–56, 1256.e1-5.
- Vincent JL, Pereira AJ, Gleeson J, Backer D. Early management of sepsis. Clin Exp Emerg Med. 2014 Sep 30;1(1):3–7.
- Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247.
- Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014;60:1310–1324.
- Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. U. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764–9
- Wu J, Hu L, Zhang G, Wu F, Fenping Wu, Taiping He. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PloS One 2015;10:e0133057.
- Takahashi G, Shibata S, Ishikura H et al. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study. Eur J Anaesthesiology 2015;32:199–206.
- Albillos A, de la Hera A, Gozales M. et al. Increased lipopolysaccharide binding protein in cirrotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208–17.
- Elefsiniotis I, Tsakiris SA, Barla G, Tasovasili A, Vrachatis D, Mavrogiannis C. Presepsin levels in cirrhotic patients with bacterial infections and/or portal hypertension-related bleeding, presenting with or without acute kidney injury. Ann Gastroenterol. 2018;31(5):604–12.
- Wejnaruemarn S, Susantitaphong P, Komolmit P, Treeprasertsuk S, Thanapirom K. Procalcitonin and presepsin for detecting bacterial infection and spontaneous bacterial peritonitis in cirrhosis: A systematic review and meta-analysis. World J Gastroenterol. 2025;31(6):99506.
- Lee S, Song J, Park DW, et al. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions. BMC Infect Dis. 2022;22(1):8.
- Igna R, Muzica C, Zenovia S, et al. The value of presepsin and procalcitonin as prognostic factors for mortality in patients with alcoholic liver cirrhosis and acute on chronic liver failure. Arch Clin Cases. 2024;11(2):61–68.
- EASL clinical practice guidelines for the management of patients with decompensated cirrhosis.
- Huang YQ, Gou R, Diao YS, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15(1):58–66
- Centers for Disease Control and Prevention. CDC/NHSN surveillance definitions for specific types of infections. National Healthcare Safety Network (NHSN) Patient Safety Component Manual, Chapter 17. U.S. Department of Health & Human Services; 2025.
- Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis. J Infect Chemother. 2012;18:891–897.
- Masson S, Caironi P, Fanizza C, et al. Circulating presepsin (sCD14-ST) as a prognostic marker in severe sepsis and septic shock. Crit Care. 2014;18:R6
- Efremova I, Maslennikov R, Poluektova E, et al. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World J Hepatol. 2024;16(5):822–831.
- Lee B, Park JE, Yoon SJ, et al. No Significant Differences in Presepsin Levels According to the Causative Microorganism of Bloodstream Infection. Infect Chemother. 2024;56(1):47–56.
- Zhang X, Liu D, Liu YN, et al. The accuracy of presepsin for sepsis diagnosis and prognosis. Crit Care. 2015;19:323.
- Nagata T, Yasuda Y, Ando M, et al. Clinical impact of kidney function on presepsin levels. Clin Chim Acta. 2015;440:201–205
Language: English
Page range: 386 - 400
Submitted on: Nov 15, 2025
Accepted on: May 7, 2026
Published on: Jul 27, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Monica Mlesnite, Petra Fischer, Oana Nicoara-Farcau, Oana Antal, Elena Stefanescu, Horia Stefanescu, Emanuel Palade, Daniela Ionescu, Bogdan Procopet, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.